Celadon Pharmaceuticals (CEL) Stock Chart & Stock Price History GBX 14.70 +2.20 (+17.60%) As of 11:46 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesBuy This Stock Celadon Pharmaceuticals Stock Price Performance The Celadon Pharmaceuticals (CEL) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 82.71%, with a year-to-date return of 5.00%. In the past month, the stock has increased 194.00%, reflecting recent market activity. As of the latest close, Celadon Pharmaceuticals traded at GBX 10 with a market cap of £6.13 million and volume of 192,998 shares. Receive CEL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Celadon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+73.35%1 Month Performance+194.00%3 Month Performance-8.13%Year-To-Date Performance+5.00%1 Year Performance-82.71% CEL Stock Chart for Friday, June, 13, 2025 CEL Chart by TradingView Celadon Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/12/2025GBX 12.02GBX 10-16.82%GBX 15.90GBX 10192,998 shs£6.13 million06/11/2025GBX 14.65GBX 12.02-17.94%GBX 17GBX 12367,728 shs£7.37 million06/10/2025GBX 12.73GBX 14.65+15.08%GBX 15GBX 11209,703 shs£8.99 million06/09/2025GBX 8.48GBX 12.73+50.12%GBX 15GBX 10.20143,316 shs£7.81 million06/06/2025GBX 12GBX 8.48-29.33%GBX 15GBX 8.48102,845 shs£5.20 million06/05/2025GBX 15GBX 12-20.00%GBX 15GBX 1296,856 shs£7.36 million06/04/2025GBX 14.76GBX 15+1.63%GBX 15GBX 12485,542 shs£9.20 million06/03/2025GBX 9.50GBX 14.76+55.37%GBX 18GBX 9711,641 shs£9.05 million06/02/2025GBX 5GBX 9.50+90.00%GBX 15GBX 3.95539,837 shs£5.83 million05/30/2025GBX 5GBX 5GBX 5GBX 416,737 shs£3.07 million Get the Latest News and Ratings for CEL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Celadon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/29/2025GBX 5GBX 5GBX 5GBX 444,615 shs£3.07 million05/28/2025GBX 4.60GBX 5+8.70%GBX 5GBX 47,598 shs£3.07 million05/27/2025GBX 4.60GBX 4.60GBX 5GBX 415,231 shs£2.82 million05/26/2025GBX 4.60GBX 4.60GBX 5GBX 4.5512,334 shs£2.82 million05/23/2025GBX 5GBX 4.60-8.00%GBX 5GBX 4.5512,334 shs£2.82 million05/22/2025GBX 4.83GBX 5+3.63%GBX 5GBX 41,544 shs£3.07 million05/21/2025GBX 5GBX 4.83-3.50%GBX 5GBX 4132,207 shs£2.96 million05/20/2025GBX 4.55GBX 5+9.89%GBX 5GBX 4214,134 shs£3.07 million05/19/2025GBX 6GBX 4.55-24.17%GBX 5GBX 3.10495,284 shs£2.79 million05/16/2025GBX 6GBX 6GBX 6GBX 4292,083 shs£3.68 million05/15/2025GBX 6GBX 6GBX 6GBX 45,409 shs£3.68 million05/14/2025GBX 5GBX 6+20.00%GBX 6GBX 4.559,029 shs£3.68 million05/13/2025GBX 5GBX 5GBX 5.40GBX 433,106 shs£3.07 million05/12/2025GBX 5GBX 5GBX 5.40GBX 433,106 shs£3.07 million Related Companies Cambridge Nutritional Sciences Stock Chart Beacon Energy Stock Chart Fox Marble Stock Chart Vodafone Group Public Stock Chart BT Group Stock Chart BBGI Global Infrastructure Stock Chart Pacific Horizon Investment Trust Stock Chart Provexis Stock Chart Argent BioPharma Stock Chart N4 Pharma Stock Chart Receive CEL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Celadon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (LON:CEL) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Celadon Pharmaceuticals Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Celadon Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CEL Stock Free CEL Stock Alerts